The 2026 Ebola outbreak is hampered by a lack of vaccine against the species of the virus, heightening the need for rapid tests to aid in disease control

The 2026 Ebola outbreak in the DRC is spurring new Ebola vaccine development for the Bundibugyo species.

See the evolution of Ebola vaccine and treatment development

The recently approved vaccine and treatments against Ebola are the result of many years of investments and have reshaped how the world addresses Ebola outbreaks. Four drugs were tested in the midst of the 2014 outbreak. Two proved to be so effective the clinical trial ended early. The vaccine proved effective during the 2018-2020 outbreak in the DRC.

The 2026 Ebola outbreak in the DRC is spurring new Ebola vaccine development for the Bundibugyo species

An experimental vaccine candidate from Moderna will use the company's mRNA vaccine platform—the same one which enabled the COVID-19 vaccine to be rapidly developed during the pandemic.

An Ebola vaccine was developed during the 2018 west African Ebola outbreak, but the 2026 Ebola outbreak is with a different species of the virus, not the one that the vaccine is approved to treat.

See the evolution of Ebola vaccine and treatment development.

Three Ebola species are responsible for most large outbreaks of the disease, yet the only approved Ebola vaccine is known to work against just one of them.

Three Ebola species are responsible for most large outbreaks of the disease

The Ebola Zaire, Sudan, and Bundibugyo species are the three ebolaviruses responsible for most large outbreaks in Africa. Among these, Ebola Zaire is the deadliest, with as many as 90% of cases resulting in death. Ebola Sudan has about a 50% fatality rate and has caused several outbreaks in Uganda. More recently discovered in 2007, Bundibugyo causes death in about 30% of people and has caused two large outbreaks in Uganda and the Democratic Republic of the Congo (DRC) before the spring 2026 DRC outbreak. Taï Forest virus is the rarest and is known to have infected a single person in the Côte d'Ivoire in 1994.

An Ebola vaccine was developed during the 2018 west African Ebola outbreak

A study found that Merck's rVSV-ZEBOV Ebola vaccine (called Ervebo) was 84% effective against infection during the 2018-2020 Ebola outbreak in the DRC. This effect was observed for both sexes and among children and adults. The vaccine is approved to help provide protection against one specific species of the Ebola virus. The 2026 Ebola outbreak is with a different species of the virus—not the one that the vaccine is approved to treat.

There have been close to 40 Ebola outbreaks since 1976

Ebola is a rare but deadly virus that causes severe illness, organ damage, and sometimes internal bleeding. It spreads through contact with infected bodily fluids and is most common in parts of sub-Saharan Africa. This explainer covers its symptoms, transmission, and treatment options.

See how Ebola tore through Guinea, Sierra Leone, and Liberia in 2014-2016.

See how Ebola tore through Guinea, Sierra Leone, and Liberia in 2014-2016

Frontline traced how the outbreak started and spread across West Africa. documenting first-hand accounts and patient experiences. This Ebola outbreak was the deadliest to date, resulting in over 11,000 deaths.

Scientists have struggled to pin down Ebola's natural reservoir species for decades, but the available evidence suggests that it's very likely fruit and insect-eating bats found in Africa.

Ebola's natural reservoir species are likely bats

But the virus doesn't seem to sicken the animals, so capturing an infected bat and performing necessary tests has remained challenging. Though many scientists believe fruit bats are the reservoir species for the virus, Ebola viral RNA fragments were detected in a greater long-fingered bat captured in 2016 in Liberia. The species isn't a fruit bat—it roosts in caves and feeds on insects. The scientist behind the discovery states that he believes the virus likely infects multiple host species and that the hosts may differ regionally. (Some users may encounter a paywall.)

Marburg virus, related to Ebola, is also extremely deadly

Discovered nine years before Ebola, Marburg is part of the same filovirus family. While this virus is less contagious, it can still be deadly. Currently, no vaccines exist against this disease. (Some users may encounter a paywall.)

Ebola species have historically been named after where they were discovered, stigmatizing residents who live there, including Bundibugyo, in Uganda.

Cultural norms about how to handle the bodies of loved ones have hampered Ebola responses in West Africa

Awareness of local burial and grieving traditions eventually helped healthcare workers fight the spread of the virus. As healthcare workers and burial teams altered their procedures during the 2014 West African Ebola outbreak, and as community leaders pressed people to adapt traditional ceremonies, the spread of Ebola began to slow.

How the most famous Ebola outbreak book got aspects of the disease so wrong

Richard Preston's 1994 book The Hot Zone brought knowledge of Ebola to the masses. But, beyond the poor portrayals of the science and the scientists, the book fostered fearmongering about Ebola, with portrayals of "liquefying," "dissolving," and "bleeding out." These falsehoods about Ebola have persisted for decades and appear to be reinvigorated with every new emergence of the disease.

Marburg virus, related to Ebola, is also extremely deadly, and has no available vaccine.

Watch what the Ebola virus does inside our cells and organs in order to spread and survive.

Cultural norms about how to handle the bodies of loved ones in communities in West Africa have hampered Ebola responses.

How the most famous Ebola book, The Hot Zone, which sold 3.5 million copies and was translated into 30 languages, got aspects of the disease so wrong.

Learn how monoclonal antibodies, which mimic the body's antibodies, can fight diseases like Ebola.

Explore what it's like Inside a patient isolation unit

Containing a contagious disease like Ebola requires strict protective measures. There are several specialized medical wards to contain deadly infectious diseases at hospitals across the U.S. Emory University has one such unit, where 4 patients were treated during the 2014 outbreak.

Explore what it's like inside a patient isolation unit, used in situations such as treating a patient or suspected patient with Ebola.

Learn how monoclonal antibodies, which mimic the body's antibodies, can fight diseases like Ebola

Monoclonal Antibodies mimic the antibodies produced naturally by the immune system. These molecules target specific parts of the virus, preventing them from entering cells or interfering with their ability to cause harm or infection.

Watch how viruses like Ebola can spill over from animals to humans—and vice-versa.

See how the Ebola virus affects blood circulation in the human body

Ebola infects and disables immune cells, causing a cascade of events that result in small blood clots throughout the body, weakening blood vessels, and interrupting blood flow to key organs.

Ebola is a filovirus, meaning it resembles a thread under a microscope, though it sometimes twists and can resemble a bowl of spaghetti.

Vector-borne diseases kill more than 700,000 people globally each year—and are growing

The diseases with the greatest potential to spread widely aren't the ones that quickly kill human hosts. Instead, the best hosts or reservoirs for vector-borne diseases would be chronically ill over the long term, increasing the likelihood that the pathogen could be transmitted to others.

Leprosy symptoms may appear 20 years after infection, so contact tracing isn't possible

The standard approach for tracking disease transmission isn't realistic for this disease because symptoms may take decades to manifest. As a result, disease transmission is still not fully understood.

Experimental hantavirus vaccines and therapies, still under development, have long been funded by the US military.

Watch an expert's take on the rare disease hantavirus—and why it's not of great concern to the general population

This rare zoonotic disease, transmitted to humans primarily through infected rodent droppings, urine, or saliva, is rarely spread between people. The disease was of particular concern in spring 2026, when an outbreak occurred on a 150-person cruise ship, prompting a flurry of action, including contact tracing for passengers in their home countries. The disease can be fatal. But early care—primarily oxygen support—can help patients survive.

Wild chimpanzees have been spotted with leprosy lesions

In research published in 2021, scientists reported discovering cases of leprosy in wild chimpanzees from Guinea-Bissau and the Ivory Coast—marking the first time the disease has been found in any nonhuman species in Africa. They confirmed that leprosy was the cause of the deformities by testing the animals' poop for the presence of the disease-causing bacteria.

CDC does not require docs to report hand, foot, and mouth cases which makes tracking difficult

Mid-Atlantic states saw a surge of hand, foot, and mouth disease in 2025 for as-yet unknown reasons. Virginia, Maryland, and New Jersey, reported elevated outbreak numbers in 2025 as compared to other recent years, but since the US Centers for Disease Control and Prevention does not require mandatory reporting of positive HFMD cases—unlike strictly notifiable diseases like measles—it's hard to truly know the extent of the outbreaks and how significant the caseload is as compared to prior years across the region or country.

Wastewater testing has detected genetic evidence of polio, triggering vaccine boosters

Sampling of wastewater in London in 2022 detected fragments of polio virus, suggesting a vaccine-derived version of polio may be circulating. No one became ill, but the finding did trigger calls for a renewed booster inoculation campaign.

This real-time tracking of the hantavirus cruise ship outbreak in May 2026 offers a unique glimpse into the global reach of the outbreak and whether the virus sickened passengers and their communities around the world.

West Nile is named after the district in Uganda where it was first isolated from a patient

In 1937, scientists isolated the virus from a woman in the West Nile District of Uganda. It's since been detected in much of Africa, Eastern Europe, West Asia, the Middle East, and was first detected in US patients during an outbreak in 1999.

Since 1600, the longest stretch without an outbreak that killed 10,000 was four years

We think of pandemics as unlikely events, but disease outbreaks are surprisingly common. Over the past 400 years, the longest stretch without an outbreak that killed at least 10,000 people was just four years. The next pandemic can't be precisely known, so experts and policymakers focus on preparation.

Visualizing the genetics of SARS-CoV-2

The COVID-19 pandemic, caused by the SARS-CoV-2 virus, began with an outbreak in Wuhan, China in December 2019, and rapidly spread worldwide in early 2020. On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic, leading to widespread lockdowns, travel restrictions, and economic disruptions.

The Chinese market for donkey hides has created a new source of diseases

Since 1992, China’s donkey population has dropped more than 80 percent. This report examines how China’s booming demand for a traditional medicine known as e-jiao, made from collagen from donkey hides, is leading to the slaughter of 6 million African donkeys annually, and providing a new source for zoonotic diseases.

Dr. William Gorgas eradicated yellow fever in Panama, crucial to canal construction

The disease was one of the factors hampering the French effort to build the canal. Gorgas' experience elsewhere in the Caribbean had taught him that good drainage and quaranting patients were essential, and he would eventually apply mosquito prevention tactics on a mass scale.

Many of the new prenatal genetic tests for rare genetic conditions are inaccurate

Established screening tests for Down syndrome in utero are reliable and accurate. But a New York Times investigation into expanded prenatal genetic tests for very rare diseases—much rarer than Down syndrome—found that more than 80 percent of the positive test results turned out to be wrong based on follow-up testing. These expanded tests for rare diseases are performed from a blood draw at 10 weeks of pregnancy and aim to detect chromosomal abnormalities linked to rare diseases. Companies that offer these controversial tests counter that it's only a screening test—not a diagnosis—picking up true positives and noting that patients can and should be counseled about what the findings mean. (Some users may encounter a paywall.)

Indefinite cloning of some endangered species may not sustain their longevity because cloning success rates decrease as genetic mutations accumulate.

Telehealth demand for GLP-1s for weight loss is booming as consumers seek easier access.

About 12.5% of US adults experience a phobia in their lifetime, a diagnosis that hinges on the intense fear interfering with daily life and persisting for at least six months.

Scientists testing how climate change affects plants found, in a years-long simulation study, that poison ivy grew 70% faster with the resulting extra carbon dioxide.

Electrical grids worldwide must double their power delivery capacity by 2050 to meet surging demand from AI and electric vehicles.

The United States has had a tumultuous relationship with Cuba since its 1959 revolution, highlighted by a nuclear crisis and a decades-long trade embargo.

Louisiana's 'Cancer Alley' is infamous for having some of the highest industrial pollution, toxic air emissions, and cancer risks in the US.

Search a massive database of over 4 decades of clues from the TV quiz show 'Jeopardy!'